XML 110 R3.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statments of Earnings - CAD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Profit or loss [abstract]      
Product sales $ 24,394 $ 22,282 $ 18,360 [1]
Less: royalties (1,523) (1,255) (1,018)
Revenue 22,871 21,027 17,342
Expenses      
Production 6,277 6,464 5,675 [1]
Transportation, blending and feedstock 4,699 4,189 3,529 [1]
Depletion, depreciation and amortization 5,546 5,161 5,186
Administration 344 325 319
Share-based compensation 223 (146) 134
Asset retirement obligation accretion 190 186 164
Interest and other financing expense 836 739 631
Risk management activities 77 (134) 35
Foreign exchange (gain) loss (570) 827 (787)
Gain on acquisition, disposition and revaluation of properties 0 (452) (379)
Loss (gain) from investments 293 346 (38)
Total expenses 17,915 17,505 14,469
Earnings before taxes 4,956 3,522 2,873
Current income tax expense (recovery) 434 374 (164)
Deferred income tax (recovery) expense (894) 557 640
Net earnings $ 5,416 $ 2,591 $ 2,397
Net earnings per common share      
Basic earnings per share (in CAD per share) $ 4.55 $ 2.13 $ 2.04
Diluted earnings per share (in CAD per share) $ 4.54 $ 2.12 $ 2.03
[1] In connection with adoption of IFRS 15 on January 1, 2018, the Company has reclassified certain comparative amounts in a manner consistent with the presentation adopted for the year ended December 31, 2018.